Latest Kratom Study Unlikely To Change FDA Stance

Critics expect FDA already has reached conclusion about compelling making kratom a controlled substance. “Their conclusion seems to be pretty well preordained,” says NPA CEO Daniel Fabricant.

• Source: Shutterstock

An exploratory study the Food and Drug Administration is funding about what US consumers kratom users know about the botanical appears to some as an attempt to gather information to support a conclusion the agency’s already reached.

“It appears FDA is endeavoring to lay a foundation for renewed argument to schedule kratom as a controlled substance or...

Welcome to HBW Insight

Create an account to read this article

More from Regulation

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

US FDA Has Lists To Assure Progress On Supplement Sector Regulations, NDIN Guidance

 

The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

EU Industry Wants EFSA Changes To Support Innovation

 
• By 

Prominent trade groups call on the European Commission to improve risk assessment of innovative food products by making changes to processes at the European Food Safety Authority.

More from Policy & Regulation

US FDA Has Lists To Assure Progress On Supplement Sector Regulations, NDIN Guidance

 

The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

Utah Delegation’s Support For Supplement Industry Key For Caucus Restart In Congress

 

Dietary Supplement Caucus e-launched the 119th Congress with Utah Republican House member Mike Kennedy and Texas Democrat member Marc Veasey as co-chairs and with a total of nine senators and 20 House members spanning both parties.